Notably, one of the mutations driving the myeloproliferative neoplasm (MPN) development is that of the calreticulin-encoding CALR gene; this mutation activates MPL/JAK/STAT signaling in MPN stem cells, thereby promoting better survival and expansion outside the bone marrow niche [279]. The gene discussed is CALR; the disease is myeloproliferative disorder.